Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1,800 | 2 | 88.2% |
| Food and Beverage | $241.61 | 12 | 11.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $1,800 | 2 | $0 (2018) |
| Sunovion Pharmaceuticals Inc. | $81.18 | 6 | $0 (2021) |
| Becton, Dickinson and Company | $73.17 | 2 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $65.66 | 3 | $0 (2017) |
| Phadia US Inc. | $21.60 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $23.17 | 1 | Becton, Dickinson and Company ($23.17) |
| 2021 | $69.51 | 2 | Becton, Dickinson and Company ($50.00) |
| 2020 | $17.52 | 1 | Sunovion Pharmaceuticals Inc. ($17.52) |
| 2018 | $1,866 | 7 | Genentech USA, Inc. ($1,800) |
| 2017 | $65.66 | 3 | AstraZeneca Pharmaceuticals LP ($65.66) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/24/2022 | Becton, Dickinson and Company | — | Food and Beverage | In-kind items and services | $23.17 | General |
| 04/15/2021 | Becton, Dickinson and Company | BD Pharmingen (Device) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Cell Analysis | ||||||
| 03/19/2021 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: CNS | ||||||
| 11/10/2020 | Sunovion Pharmaceuticals Inc. | KYNMOBI (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: CNS | ||||||
| 09/05/2018 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: CNS | ||||||
| 08/15/2018 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $6.57 | General |
| Category: CNS | ||||||
| 06/25/2018 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $21.60 | General |
| Category: Allergy/Immunology | ||||||
| 05/31/2018 | Genentech USA, Inc. | Non-Covered Product (Drug) | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| Category: None | ||||||
| 04/30/2018 | Genentech USA, Inc. | Non-Covered Product (Drug) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: None | ||||||
| 04/04/2018 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $9.87 | General |
| Category: CNS | ||||||
| 03/30/2018 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: CNS | ||||||
| 05/17/2017 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/29/2017 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/15/2017 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 92 | 94 | $26,750 | $4,269 |
| 2022 | 1 | 58 | 60 | $18,000 | $3,097 |
| 2021 | 1 | 63 | 64 | $17,550 | $3,342 |
| 2020 | 1 | 42 | 43 | $10,750 | $2,257 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88188 | Flow cytometry technique for dna or cell analysis, 9 to 15 markers | Facility | 2023 | 67 | 69 | $20,700 | $3,542 | 17.1% |
| 88187 | Flow cytometry technique for dna or cell analysis, 2 to 8 markers | Facility | 2023 | 25 | 25 | $6,050 | $726.25 | 12.0% |
| 88188 | Flow cytometry technique for dna or cell analysis, 9 to 15 markers | Facility | 2022 | 58 | 60 | $18,000 | $3,097 | 17.2% |
| 88188 | Flow cytometry technique for dna or cell analysis, 9 to 15 markers | Facility | 2021 | 63 | 64 | $17,550 | $3,342 | 19.0% |
| 88188 | Flow cytometry technique for dna or cell analysis | Facility | 2020 | 42 | 43 | $10,750 | $2,257 | 21.0% |
About Jack Bui, M.D., PH.D
Jack Bui, M.D., PH.D is a Clinical Pathology/Laboratory Medicine healthcare provider based in La Jolla, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/18/2010. The National Provider Identifier (NPI) number assigned to this provider is 1942529821.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jack Bui, M.D., PH.D has received a total of $2,042 in payments from pharmaceutical and medical device companies, with $23.17 received in 2022. These payments were reported across 14 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($1,800).
As a Medicare-enrolled provider, Bui has provided services to 255 Medicare beneficiaries, totaling 261 services with total Medicare billing of $12,965. Data is available for 4 years (2020–2023), covering 5 distinct procedure/service records.
Practice Information
- Specialty Clinical Pathology/Laboratory Medicine
- Location La Jolla, CA
- Active Since 05/18/2010
- Last Updated 10/17/2018
- Taxonomy Code 207ZP0105X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1942529821
Products in Payments
- Non-Covered Product (Drug) $1,800
- BRILINTA (Drug) $65.66
- APTIOM (Drug) $63.66
- BD Pharmingen (Device) $50.00
- ImmunoCAP (Device) $21.60
- KYNMOBI (Drug) $17.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.